- Beat earnings estimates in all of the last 4 quarters
- Excellent financial health (Piotroski 8/9)
- Healthy interest coverage ratio of 28.8x
Stronger technical forecast for ASTELLAS PHARMA INC stock price after Tuesday trading
(Updated on Jul 14, 2026)
The ASTELLAS PHARMA INC stock price gained 1.22% on the last trading day (Tuesday, 14th Jul 2026), rising from $13.07 to $13.23. During the last trading day the stock fluctuated 0.83% from a day low at $13.22 to a day high of $13.33. The price has fallen in 5 of the last 10 days and is down by -1.56% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 11 thousand more shares were traded than the day before. In total, 20 thousand shares were bought and sold for approximately $262.68 thousand.
The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.41% during the next 3 months and, with a 90% probability hold a price between $10.60 and $11.50 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ALPMY Signals & Forecast
There are mixed signals in the stock today. The ASTELLAS PHARMA INC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.27 and $13.40. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has risen 1.46%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). ASTELLAS PHARMA INC has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for ASTELLAS PHARMA INC stock
ASTELLAS PHARMA INC finds support from accumulated volume at $13.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.110 between high and low, or 0.83%. For the last week the stock has had daily average volatility of 0.653%.
Our recommended stop-loss: $12.49 (-5.63%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 8 days ago.)
Trading Expectations (ALPMY) For The Upcoming Trading Day Of Wednesday 15th
For the upcoming trading day on Wednesday, 15th we expect ASTELLAS PHARMA INC to open at $13.26, and during the day (based on 14 day Average True Range), to move between $13.08 and $13.38, which gives a possible trading interval of +/-$0.295 (+/-2.26%) up or down from last closing price. If ASTELLAS PHARMA INC takes out the full calculated possible swing range there will be an estimated 2.26% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $13.19 (0.30%) than the resistance at $13.30 (0.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is ASTELLAS PHARMA INC stock A Buy?
ASTELLAS PHARMA INC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.024
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 15, 2026 - $13.26 ( 0.227%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ALPMY Performance
Trading levels for ALPMY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.37 | 1.06% |
| R2 | 13.33 | 0.741% |
| R1 | 13.30 | 0.544% |
| Price | 13.23 | |
| S1 | 13.22 | -0.0909% |
| S2 | 13.19 | -0.287% |
| S3 | 13.15 | -0.605% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.30 | 8.09% |
| R2 | 13.49 | 1.97% |
| R1 | 13.30 | 0.529% |
| Price | 13.23 | |
| S1 | 13.19 | -0.302% |
| S2 | 13.16 | -0.529% |
| S3 | 13.15 | -0.605% |
ALPMY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 31, 2026 | Mar 31, 2026 | Mar 31, 2026 | $0.214 | 1.32% |
| 2 | Mar 30, 2026 | Mar 30, 2026 | Jun 03, 2026 | $0.244 | 1.48% |
| 3 | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | $0.226 | 2.08% |
| 4 | Mar 31, 2025 | Mar 31, 2025 | Mar 31, 2025 | $0.214 | 2.22% |
| 5 | Sep 30, 2024 | Sep 30, 2024 | Sep 30, 2024 | $0.227 | 1.98% |
FAQ
Click here for our free guide on how to buy ASTELLAS PHARMA INC Stock.
Buy ALPMY